AAC TECH (02018) spent 11.7723 million Hong Kong dollars on January 23 to repurchase 30.45 thousand shares.
Raytron Technology (02018) announced that on January 23, 2025, the company invested HK$11.7723 million...
AAC TECH (02018) announced that on January 23, 2025, the company repurchased 30.45 thousand shares for a total of 11.7723 million Hong Kong dollars, at a repurchase price of 38.35-39.65 Hong Kong dollars per share.
Related Articles
Filling a clinical gap! GRAND PHARMA (00512) CBT-001 significantly controls pterygium lesions, deepening its presence in the innovative ophthalmic drug track and targeting a blue ocean market worth tens of billions
Hinova Pharmaceuticals (688302.SH) Signs Exclusive Licensing Agreement to Advance Overseas Market Development of HP570
GRAND PHARMA (00512): Global Innovative Ophthalmic Drug CBT-001 for Pterygium Meets Primary Clinical Endpoint in International Multicenter Phase III Clinical Trial
Filling a clinical gap! GRAND PHARMA (00512) CBT-001 significantly controls pterygium lesions, deepening its presence in the innovative ophthalmic drug track and targeting a blue ocean market worth tens of billions
Hinova Pharmaceuticals (688302.SH) Signs Exclusive Licensing Agreement to Advance Overseas Market Development of HP570
GRAND PHARMA (00512): Global Innovative Ophthalmic Drug CBT-001 for Pterygium Meets Primary Clinical Endpoint in International Multicenter Phase III Clinical Trial
